Piezo Motion Expands Global Reach with New Partnership
Piezo Motion Expands Global Reach with New Partnership
Micro Technology Group will deliver motion control and automation solutions to OEM manufacturers throughout the northeastern United States
Micro Technology Group将向美国东北部的OEM制造商提供运动控制和自动化解决方案
LAKEWOOD RANCH, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB: BRSF) company, and Micro Technology Group (MTG) today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. MTG, headquartered in Mansfield, Massachusetts, is a business development company providing technical marketing and sales services for leading manufacturers.
2022年4月14日，佛罗里达州莱克伍德牧场(Global Newswire)--通过InvestorWire--脑科学公司(OTCQB：BRSF)旗下的Piezo Motion公司和微技术集团(MTG)今天宣布建立合作伙伴关系。Piezo Motion是自动化技术的开发商和领先制造商。MTG总部位于马萨诸塞州曼斯菲尔德，是一家为领先制造商提供技术营销和销售服务的业务开发公司。
Piezo Motion's unique motion control technology will enable MTG to provide affordable precision motor solutions and motion control to customers specializing in electronic components. Piezo Motion's multifaceted rotary and linear motors utilize technology offering stability and accuracy, designed specifically for Original Equipment Manufacturers (OEMs) requiring ultimate speed, size and accuracy.
Piezo Motion独特的运动控制技术将使MTG能够为专门从事电子元件的客户提供负担得起的精密电机解决方案和运动控制。Piezo Motion的多面旋转和直线电机采用了提供稳定性和精确度的技术，专为要求极限速度、尺寸和精度的原始设备制造商(OEM)设计。
"We are excited to expand our product offering with the addition of Piezo Motion's high precision, piezo-based rotary and linear motors, and micro-dosing pumps to our product portfolio," said Spencer Simons, president of MTG. "The addition of these products will allow us to broaden our motion control product capabilities and address the forward-looking technology requirements of our customers in the aerospace, defense, medical and industrial market segments."
MTG的斯宾塞·西蒙斯(Spencer Simons)表示：“我们很高兴能在我们的产品组合中加入Piezo Motion的高精度、基于压电的旋转和直线电机，以及微型配料泵，从而扩大我们的产品供应。”这些产品的增加将使我们能够扩大我们的运动控制产品能力，并满足我们客户在航空航天、国防、医疗和工业市场领域的前瞻性技术要求。“
Piezo Motion motors are used globally for a variety of applications. These include laboratory instruments, biomedicine, optics, semiconductors, nanotechnology industries, and industrial electronic and automotive systems along with an expanding portfolio of products combining performance with dramatically lower costs over conventional piezo solutions.
Piezo Motion马达在全球范围内被用于各种应用。这些领域包括实验室仪器、生物医学、光学、半导体、纳米技术行业以及工业电子和汽车系统，以及不断扩大的产品组合，这些产品结合了性能和比传统压电解决方案低得多的成本。
"We are seeing strong demand from device manufacturers and product innovators for our ultra-precise, micro-sized motors," said Hassan Kotob, chairman and CEO of Brain Scientific. "Our partnership with Micro Technology Group will give their customers access to a revolutionary product offering at a very affordable price."
Brain Science董事长兼首席执行官哈桑·科托布表示：“我们看到设备制造商和产品创新者对我们的超精密微型电机的强劲需求。”我们与微技术集团的合作将使他们的客户能够以非常实惠的价格获得革命性的产品供应。“
About Piezo Motion
关于Piezo Motion
Piezo Motion (piezomotion.com), a Brain Scientific company, is a leader in precision motor technology with multimillion-dollar investments in research and development of affordable piezoelectric motors to meet, and exceed, the needs of today's global markets. The company is committed to the development of innovative technology and motion products that enhance functionality in a multitude of applications. The company works with startups, OEMs, research institutions and industrial companies from around the world, empowering the visionaries behind their products.
Brain Science旗下的Piezo Motion(Piezomotion.com)是精密电机技术的领先者，在研发负担得起的压电式电机方面投资数百万美元，以满足并超越当今全球市场的需求。该公司致力于开发创新技术和运动产品，以增强多种应用的功能。该公司与来自世界各地的初创企业、原始设备制造商、研究机构和工业公司合作，为他们产品背后的远见卓识者赋权。
About Brain Scientific
关于脑科学
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products or investor relations, please visit brainscientific.com.
Brain Science是一家拥有多项专利和FDA批准产品的医疗技术公司。Brain Science致力于开发下一代解决方案，以推动神经诊断和OEM医疗设备的未来。Brain Science有两个产品线，涵盖神经学和精密运动。NeuroCap和NeuroEEG是智能神经诊断设备，可以简化管理、缩短扫描时间并降低成本。Piezo Motion产品线由超高效紧凑型精密电机组成，将驱动下一代医疗设备。欲了解有关Brain Science公司的公司战略、产品或投资者关系的更多信息，请访问：brainScience fi.com。
About Micro Technology Group
关于微电子科技集团
Micro Technology Group (mtgelectronics.com) is a transformational business development company providing technical marketing and sales services for leading manufacturers of semiconductors, passive components and related electronic components. Considered thought leaders in the electronics industry ecosystem, they provide extensive knowledge and expertise for their suppliers and clients on how to navigate the complexity of the design-in process. Over the past 30 years, they have helped countless manufacturers of electronic components achieve successful results.
微科技集团(mtgElectronics.com)是一家变革性的业务开发公司，为领先的半导体、无源元件和相关电子元件制造商提供技术营销和销售服务。他们被认为是电子行业生态系统中的思想领袖，为他们的供应商和客户提供广泛的知识和专业知识，指导他们如何驾驭复杂的设计过程。在过去的30年里，他们帮助无数电子元件制造商取得了成功。
Forward-Looking Statements
前瞻性陈述
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
本新闻稿中包含的任何不描述历史事实的陈述都可能构成前瞻性陈述。前瞻性陈述可能包括但不限于以下陈述：(I)未来业务的管理计划和目标，包括与脑电产品和服务以及压电电机技术的设计、开发和商业化有关的计划或目标；(Ii)收入(包括收入/亏损)、每股收益(包括收益/亏损)、资本支出、股息、资本结构或其他财务项目的预测；(Iii)公司未来的财务表现；(Iv)Piezo Motion与Brain Science的成功整合；以及(V)以上第(I)、(Ii)、(Iii)或(Iv)点所述任何陈述所依据的或与之有关的假设。此类前瞻性陈述不是为了预测或保证实际结果、业绩、事件或情况，也可能无法实现，因为它们是基于公司目前的预测、计划、目标、信念、预期、估计和假设，受许多风险、不确定性和其他影响的影响，其中许多是公司无法控制的。由于这些风险和不确定性，某些事件和情况的实际结果和时间可能与前瞻性陈述中描述的大不相同。可能影响或导致前瞻性陈述不准确或导致实际结果与预期或期望结果大不相同的因素可能包括但不限于, 该公司无法获得更多融资；与开发产品和相关产品相关的时间和资源过长；现金流不足和由此导致的流动性不足；该公司无法扩大其业务；政府对医疗器械和医疗保健行业的监管力度较大；缺乏产品多元化；该公司原材料价格波动；以及未能实施该公司的业务计划或战略。在该公司提交给美国证券交易委员会的文件中，对其中一些因素以及其他一些因素进行了识别和更详细的描述。该公司不承诺更新这些前瞻性陈述。
CONTACTS
触点
INVESTORS
ir@brainscientific.com
投资商
邮箱：ir@brainScience fic.com
MEDIA
pr@brainscientific.com
媒体
电子邮箱：pr@brainScience fic.com
Corporate Communications
企业通信
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
IBN(InvestorBrandNetwork)
加利福尼亚州洛杉矶
310.299.1717办公室
邮箱：EDITOR@InvestorBrandNetwork.com
译文内容由第三方软件翻译。